UHS Earnings

UHS reported its earnings on 2026-02-25, showcasing a revenue of against an estimate of 4.48B, resulting in a 0% surprise. The EPS was 0, surpassing the expected 5.92 by 0%. The stock experienced a -11.44% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following UHS's earnings announcement on 2026-02-25, the stock price moved by -11.44% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, UHS's stock price tends to shift by an average of 0.52% in the 10 days leading up to earnings and 2.81% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate UHS's annual revenue to reach 4.34B, while the EPS is projected at 5.32. These estimates reflect recent revisions, with revenue estimates revised upward by 0.07% and EPS estimates revised upward by 0.03% over the past three months, indicating analyst expectation in the company's performance.

The correlation between UHS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.07%, while EPS estimates moved revised upward by 0.03%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, UHS's stock price typically moves by 0.52% in the 10 days before its earnings and 2.81% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 5.32 and revenue of 4.34B.

The earnings call presented optimistic guidance with a 6% increase in EPS, promising hospital openings, and growth in behavioral health and acute care segments. The Q&A section reinforced confidence in achieving growth targets and margin expansion. Despite uncertainties in Medicaid and staffing requirements, the company's strategic investments and AI-driven efficiencies suggest a positive outlook. The positive sentiment from management and analysts, combined with strategic growth plans, indicates a likely positive stock price reaction over the next two weeks.